Gp. Rizzardi et al., Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count, AIDS, 14(15), 2000, pp. 2257-2263
Objective: When to start highly active antiretroviral therapy (HAART) in as
ymptomatic chronically HIV-l-infected subjects with CD4 cell counts of 300
x 10(6)-500 x 10(6)/l is debated extensively. Retrospective analyses of vir
ological and immunological responses following HAART have been evaluated in
both blood and lymph nodes according to pre-treatment levels of CD4 cells
either above or below 500 x 10(6)/l.
Design: Open-label, observational, non-randomized, prospective study.
Setting: Outpatients attending the Centre of Clinical Investigation in Infe
ctious Diseases, Centre Hospitalier Universitaire Vaudois, University of La
usanne, Switzerland.
Participants: Fifty-four HIV-l-infected antiretroviral-naive subjects with
CD4 cell count greater than or equal to 250 x 10(6)/l and plasma viraemia g
reater than or equal to 5000 copies/ml who had been treated with HAART for
at least 48 weeks. Controls were 49 HIV-negative subjects.
Interventions: All patients received abacavir, nelfinavir, saquinavir soft
gel capsules, and amprenavir in varying combinations for 72 weeks.
Main outcome measures: The extent of immune reconstitution following HAART
in 43 and 11 subjects with either more or fewer than 500 x 10(6) CD4 cells/
l at baseline was evaluated in blood and lymph node, and compared with immu
nological measures observed in 49 HIV-negative controls.
Results: After 48 weeks of therapy, plasma viraemia was suppressed effectiv
ely in both groups of patients. Normalization of both CD4 cell count in blo
od, divided equally between memory and naive cells, and percentage of CD4 c
ells in lymph nodes occurred in the two groups. Consistently, the net incre
ase over baseline in CD4 cell count and in memory and naive CD4 subsets was
greater in patients with fewer than 500 x 10(6) CD4 cells/l at baseline. R
ecovery of HIV-specific responses was similar in the two groups.
Conclusions: This study suggests that virological and immunological respons
es are comparable in asymptomatic therapy-naive HIV-l-infected subjects wit
h CD4 cell counts above or below 500 x 10(6)/l. (C) 2000 Lippincott William
s & Wilkins.